4200 MARATHON BLVD., AUSTIN, TX
News, Reorganization Plan, Articles of Incorporation, Bylaws
Phase 2 OraGrowtH Data at ESPE 2024 Shows Growth with LUM-201
Earnings Release
Investor Presentation
New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024
Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
Annual Report to Security Holders
Q3
Q2
Q1
FY 2023 amended
FY 2023
Notice of Suspension of Duty to File Reports
Administrative Withdrawal
Effectiveness Notice
Solicitation/Recommendation Statement
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
S-8 POS